Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660382 · ClinicalTrials.gov registry record · Phase 3
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
A Phase 3 study of Otomycosis, sponsored by Hill Dermaceuticals.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 7
- Study locations
NCT05660382 is a Phase 3 study of Otomycosis that is actively recruiting participants, run by Hill Dermaceuticals. The registered enrollment target is 100 participants. The trial reports 7 study locations across 5 states.
The verdict
NCT05660382, a Phase 3 study of Otomycosis, is actively recruiting participants, sponsored by Hill Dermaceuticals.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this clinical trial is to prove the that miconazole oil works well on fungal infections of the ears, by comparing the drug with a placebo. The researcher or the participants will not know if they are getting the drug or the placebo. The researcher will show the participants how to use the drug or placebo. After 14 days of using the drug or placebo, the participants will be examined by the researcher and graded on how well the drug worked on the ear(s) fungal infection. Participants will also be checked and asked for any bad side effects from the drug or the placebo.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Miconazole (2%) oil and mineral oil
Study Locations (7)
South Carolina
- Charleston ENT Associates, LLC - North Charleston
- Carolina ENT - Orangeburg
- Spartanburg / Greer ENT & Allergy - Spartanburg
California
- Head and Neck Surgery Specialist - Chula Vista
Kentucky
- Advanced ENT & Allergy - Louisville
Texas
- Alamo ENT Associates - San Antonio
Utah
- ENT Center Of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-02 |
| Est. Completion | 2024-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05660382
The ClinicalTrials.gov registry entry for NCT05660382 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill Dermaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Otomycosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05660382 reports 7 study locations spanning 5 distinct geographic areas - top geographies include South Carolina, California, Kentucky.
Frequently Asked Questions
What is clinical trial NCT05660382 about?
NCT05660382 is a clinical study titled "Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis". The goal of this clinical trial is to prove the that miconazole oil works well on fungal infections of the ears, by comparing the drug with a placebo. The researcher or the participants will not know if they are getting the drug or the placebo. The researcher will show the participants how to use th...
What is the current status of trial NCT05660382?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2023-03-02. Estimated completion is 2024-11.
What conditions does trial NCT05660382 study?
This clinical trial studies the following conditions: Otomycosis.
What interventions are being tested in trial NCT05660382?
The interventions under investigation include: Placebo (OTHER), Miconazole (2%) oil and mineral oil (DRUG).
Who is sponsoring clinical trial NCT05660382?
This trial is sponsored by Hill Dermaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05660382 being conducted?
This trial has 7 study locations across California, Kentucky, South Carolina, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.